Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Vancomycin-associated acute kidney injury: a cross-sectional study from a single center in china
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: ZHOU, Ying (Peking University First Hospital, Department of Pharmacy, Beijing, China)
- Co-author(s): Ying ZHOU: Department of Pharmacy, Peking University First Hospital, Beijing, China
Li YANG: Department of Nephrology, Peking University First Hospital, Beijing, China
Yimin CUI: Department of Pharmacy, Peking University First Hospital, Beijing, China
BackgroundAKI is still the main serious ADR experienced by patients receiving VAN treatment. Some studies have reported AKI incidences of up to 40%.it is clinically important to confirm the risk factors for VA-AKI to help guide clinicians toward the more rational administration of VAN.
PurposeThe objective of this study was to investigate the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019